Cilastatin

Cilastatin is a renal dehydropeptidase inhibitor primarily used in combination with imipenem to prevent its renal metabolism. This pharmaceutical compound effectively extends the antibacterial activity of imipenem by inhibiting its breakdown in the kidneys.

**Properties**:
– Highly water-soluble compound
– Stable under normal storage conditions
– Works synergistically with beta-lactam antibiotics

**Applications**:
1. **Pharmaceutical Combinations**: Used exclusively with imipenem in antibiotic formulations
2. **Hospital Medicine**: Critical component in broad-spectrum antibiotic therapies
3. **Infectious Disease Treatment**: Enhances efficacy against resistant bacterial strains

**Effects**:
– Prevents renal degradation of co-administered imipenem
– Extends antibiotic half-life in the body
– Improves treatment outcomes for severe infections

### Key Advantages:
– Essential for maintaining therapeutic levels of imipenem
– Critical for treating hospital-acquired infections
– Proven safety profile in clinical use